These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 7138909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acquisition of iron from transferrin regulates reticulocyte heme synthesis.
    Ponka P, Schulman HM.
    J Biol Chem; 1985 Nov 25; 260(27):14717-21. PubMed ID: 4055798
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regulation of heme synthesis in erythroid cells: hemin inhibits transferrin iron utilization but not protoporphyrin synthesis.
    Ponka P, Schulman HM.
    Blood; 1985 Apr 25; 65(4):850-7. PubMed ID: 3978231
    [Abstract] [Full Text] [Related]

  • 6. Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes.
    Buss JL, Arduini E, Ponka P.
    Biochem Pharmacol; 2002 Dec 15; 64(12):1689-701. PubMed ID: 12445858
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR, Tran EH, Ponka P.
    Blood; 1995 Dec 01; 86(11):4295-306. PubMed ID: 7492790
    [Abstract] [Full Text] [Related]

  • 9. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
    Baker E, Vitolo ML, Webb J.
    Biochem Pharmacol; 1985 Sep 01; 34(17):3011-7. PubMed ID: 4038321
    [Abstract] [Full Text] [Related]

  • 10. Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes.
    Ponka P, Richardson D, Baker E, Schulman HM, Edward JT.
    Biochim Biophys Acta; 1988 Oct 13; 967(1):122-9. PubMed ID: 3167093
    [Abstract] [Full Text] [Related]

  • 11. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR, Ponka P.
    J Lab Clin Med; 1994 Nov 13; 124(5):660-71. PubMed ID: 7964124
    [Abstract] [Full Text] [Related]

  • 12. Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties.
    Buss JL, Neuzil J, Gellert N, Weber C, Ponka P.
    Biochem Pharmacol; 2003 Jan 15; 65(2):161-72. PubMed ID: 12504792
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone.
    Cikrt M, Ponka P, Necas E, Neuwirt J.
    Br J Haematol; 1980 Jun 15; 45(2):275-83. PubMed ID: 7437326
    [Abstract] [Full Text] [Related]

  • 16. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Relationship of the lipophilicity of the apochelator to its ability to mobilise iron from reticulocytes in vitro.
    Ponka P, Richardson DR, Edward JT, Chubb FL.
    Can J Physiol Pharmacol; 1994 Jun 15; 72(6):659-66. PubMed ID: 7954097
    [Abstract] [Full Text] [Related]

  • 17. Iron and transferrin distribution in reticulocytes incubated with heme synthesis inhibitors.
    Ponka P, Borova J, Neuwirt J.
    Biochim Biophys Acta; 1980 Nov 03; 632(4):527-35. PubMed ID: 7437473
    [Abstract] [Full Text] [Related]

  • 18. Hydrolysis of pyridoxal isonicotinoyl hydrazone and its analogs.
    Buss JL, Ponka P.
    Biochim Biophys Acta; 2003 Jan 20; 1619(2):177-86. PubMed ID: 12527114
    [Abstract] [Full Text] [Related]

  • 19. Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: examination of the intermediates involved in iron metabolism.
    Richardson DR, Ponka P, Vyoral D.
    Blood; 1996 Apr 15; 87(8):3477-88. PubMed ID: 8605367
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.